Week 3 Short Paper Veronica Horne, Southern New Hampshire

Week 3 Short Paperveronica Horneihp 604southern New Hampshire Universi

Discuss the selection of healthcare organizations used for research purposes, including reasons for choosing the organization, the importance of public-facing data, and the relevance of the organization’s research focus to healthcare analysis. Provide a comprehensive explanation of why this organization is suitable for research, referencing available data sources, research contributions, and its impact on healthcare advancements.

Paper For Above instruction

Healthcare organizations serve as fundamental pillars in the advancement of medical research, patient care, and health policy development. When selecting a healthcare organization for research purposes, several critical factors are considered, including the organization’s reputation, the scope and quality of data available, its contributions to healthcare research, and its alignment with the research objectives. In this context, the selection of St. Jude Children’s Research Hospital exemplifies these criteria, highlighting its significant role in pediatric cancer research and its commitment to transparency through public-facing data.

St. Jude Children’s Research Hospital, established in 1962, is renowned globally for its pioneering work in pediatric cancer research and treatment. Its mission to advance cures for pediatric catastrophic diseases while ensuring that families are never burdened with the cost underscores its commitment to patient-centered care. The hospital’s extensive research initiatives have led to notable improvements in survival rates and treatment protocols, making it an ideal organization for research focused on childhood cancer outcomes. The hospital’s dedication is evident in its comprehensive research programs, which include over thirty projects since its inception, with many completed, contributing valuable data to the medical community (St. Jude, 2022).

An essential aspect of selecting an organization like St. Jude for research is the accessibility of public data. The availability of Public Access Data Tables facilitates transparent and wide-ranging analysis of childhood cancer, enabling researchers to examine epidemiological patterns, treatment effectiveness, and demographic influences. These data sets include variables such as cancer type, gender, age, years since diagnosis, age at diagnosis, and treatment modalities, providing a rich resource for understanding the complexities of pediatric cancers and their outcomes (St. Jude, 2022).

The relevance of St. Jude’s research focus on childhood cancers aligns with the broader goals of healthcare analysis, which aims to improve patient outcomes through evidence-based practices. By studying the data collected from survivors, researchers can identify trends, risk factors, and disparities in treatment efficacy, ultimately contributing to personalized medicine and improved treatment protocols. The organization’s research also supports public health initiatives by informing policies and resource allocation to pediatric cancer care, emphasizing its pivotal role in healthcare advancement.

Furthermore, the organization’s transparency through public-facing data enhances its value for research. Open access to comprehensive data sets ensures that researchers, clinicians, and policymakers can collaboratively analyze and interpret findings, fostering innovation and accountability in pediatric cancer care. The data’s organization by variables such as cancer type, treatment received, and demographics helps in stratifying patient populations and tailoring interventions, which are essential steps toward precision medicine.

In conclusion, the selection of St. Jude Children’s Research Hospital for research purposes is justified by its distinguished contribution to pediatric oncology, the richness and transparency of its public data resources, and its alignment with research goals aimed at improving childhood cancer outcomes. Its reputation, extensive research history, and dedication to sharing data make it a exemplary organization for healthcare research. Analyzing data from such a reputable institution not only advances scientific knowledge but also promotes evidence-based clinical and policy decisions that can ultimately improve survival rates and quality of life for pediatric cancer patients worldwide.

References

• St. Jude Children’s Research Hospital. (2022). Timeline: From Dream to Reality. Retrieved from https://www.stjude.org/about-st-jude/our-history.html
• St. Jude Children’s Research Hospital. (2022). Public Access Data Tables. Retrieved from https://www.stjude.org/research/data-and-statistics.html
• Gittleman, H., & Kato, Y. (2014). Long-term survival among childhood cancer survivors. Pediatric Blood & Cancer, 61(10), 1820–1825. https://doi.org/10.1002/pbc.25131
• Hill, D. A., & Mulder, R. (2020). Pediatric Oncology Research and Its Impact. Journal of Pediatric Hematology/Oncology, 42(3), 177–185. https://doi.org/10.1097/MPH.0000000000001744
• Choi, Y. J., & Kim, S. H. (2018). Data transparency in healthcare: Benefits and challenges. Journal of Medical Internet Research, 20(4), e10788. https://doi.org/10.2196/10788
• Oster, M. E., & Johnson, K. J. (2017). Public health data systems: Enhancing research and policy. American Journal of Public Health, 107(S2), S172–S177. https://doi.org/10.2105/AJPH.2017.304013
• Williams, M. V., & Garces, J. P. (2016). The importance of data sharing in pediatric research. Pediatrics, 138(4), e20154629. https://doi.org/10.1542/peds.2015-4629
• Smith, S. A., & Roberts, J. M. (2019). Pediatric cancer registries and data utilization. Cancer Epidemiology, 61, 63–70. https://doi.org/10.1016/j.canep.2019.02.003
• Adams, M., & Patel, A. (2021). Advances in personalized pediatric cancer therapy. Frontiers in Oncology, 11, 588636. https://doi.org/10.3389/fonc.2021.588636
• Johnson, R. L., & Lopez, K. (2018). The role of healthcare organizations in research transparency. Health Policy and Technology, 7(1), 22–28. https://doi.org/10.1016/j.hlpt.2017.11.002